Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. (Q33551142)

28 July 2017

title

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. (English)

1 reference

28 July 2017

1 reference

0 references

19

Hugues de Thé

0 references

Guangbiao Zhou

14

object named as

Guang-Biao Zhou

1 reference

Valérie Lallemand-Breitenbach

28 July 2017

9

object named as

Valérie Lallemand-Breitenbach

1 reference

28 July 2017

Xiao-Wei Zhang

1

1 reference

28 July 2017

Xiao-Jing Yan

2

1 reference

28 July 2017

Zi-Ren Zhou

3

1 reference

28 July 2017

Fei-Fei Yang

4

1 reference

28 July 2017

Zi-Yu Wu

5

1 reference

28 July 2017

Hong-Bin Sun

6

1 reference

28 July 2017

Wen-Xue Liang

7

1 reference

28 July 2017

Ai-Xin Song

8

1 reference

28 July 2017

Marion Jeanne

10

1 reference

28 July 2017

Qun-Ye Zhang

11

1 reference

28 July 2017

Huai-Yu Yang

12

1 reference

28 July 2017

Qiu-Hua Huang

13

1 reference

28 July 2017

Jian-Hua Tong

15

1 reference

28 July 2017

Yan Zhang

16

1 reference

28 July 2017

Ji-Hui Wu

17

1 reference

28 July 2017

Hong-Yu Hu

18

1 reference

28 July 2017

Sai-Juan Chen

20

1 reference

28 July 2017

Zhu Chen

21

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

328

1 reference

28 July 2017

issue

5975

1 reference

28 July 2017

page(s)

240-243

1 reference

Acute promyelocytic leukemia: from highly fatal to highly curable

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

How acute promyelocytic leukaemia revived arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

PML protein isoforms and the RBCC/TRIM motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Identification of arsenic-binding proteins in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

PML targeting eradicates quiescent leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1183424

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1183424

1 reference

28 July 2017

1 reference